EBF and dried blood spots: from recommendations to potential resolution
Are multiplex assays approvable?
Accurate-mass instrumentation should not always be the first-and-only choice for MS in the drug metabolism environment
Understanding and mitigating impact of immunogenicity on pharmacokinetic assays
Portable glucose detector developed to quantify a range of analytes
Researchers develop a new LC–MS method with potential usage in detecting ephedrine doping
European Medicines Agency publishes genomic biomarker paper
A Russian revolution
Conference Report: Bioanalysis-related highlights from the 2011 AAPS National Biotechnology Conference
Bioanalysis Young Investigator: Halil Tekin
Book Review: A Practical Guide to Implementing Clinical Mass Spectrometry Systems
LC–MS/MS bioanalytical challenge: ultra-high sensitivity assays
Potentially new isobaric metabolite of fluvastatin observed by LC–MS/MS during incurred sample analysis
Analysis of total and transferrin-bound iron in human serum for pharmacokinetic studies of iron–sucrose formulations
Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection
Validation of an LC–MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome
Case studies from the use of commercial biomarker/protein test kits
NMR spectroscopy for discovery and quantitation of biomarkers of disease in human bile